Skip to main content
Top
Published in: European Radiology 9/2020

01-09-2020 | Computed Tomography | Computed Tomography

Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection

Authors: Xiaoli Cai, Feng Gao, Yafei Qi, Gongyu Lan, Xianyi Zhang, Ruoyun Ji, Youli Xu, Chang Liu, Yu Shi

Published in: European Radiology | Issue 9/2020

Login to get access

Abstract

Objectives

To identify quantitative imaging features of contrast-enhanced computed tomography (CE-CT) that may be prognostically favorable after resection of smaller (≤ 30 mm) pancreatic ductal adenocarcinomas (PDACs) located at head.

Methods

This retrospective study included two independent cohorts (discovery cohort, n = 212; test cohort, n = 100) of patients who underwent resection of head PDACs ≤ 30 mm and preoperative CE-CT. We examined tumor and surrounding parenchymal attenuation differences (deltas), and tumor attenuation changes across phases (ratios). Semantic features of PDACs were evaluated by two radiologists. Clinicopathologic and imaging features for predicting disease-free survival (DFS) and overall survival (OS) were analyzed via multivariate Lasso-penalized Cox proportional-hazards models. Survival rates were derived by Kaplan-Meier method.

Results

Imaging features achieved C-indices of 0.766 (discovery cohort) and 0.739 (test cohort) for DFS, and 0.790 (discovery cohort) and 0.772 (test cohort) for OS estimates through incorporation of clinicopathologic features. The most decisive imaging feature was delta 3, denoting attenuation differences between tumor and surrounding pancreas at pancreatic phase (DFS: HR = 2.122; OS: HR = 2.375; both p < 0.001). Compared with inconspicuous (low-delta-3, < 28 HU) tumors, conspicuous (high-delta-3) tumors correlated significantly with more aggressive histologic grades (p = 0.014) and less extensive tumor fibrous stromal fractions (p < 0.001). Patients with low-delta-3 tumors ≤ 20 mm experienced the most favorable outcomes (DFS, 36 months; OS, 42 months), whereas those with high-delta-3 tumors fared poorly, regardless of tumor size (DFS, 12 months; OS, 19 months).

Conclusions

Quantifiable CT imaging features reflect heterogeneous fibrous stromal fractions and histologic grades of PDAC at head locations that help stratify patients with disparate clinical outcomes.

Key Points

• Quantitative and semantic imaging features achieved promising results for the prognosis of resected PDAC (≤ 30 mm) at head location, through incorporation of clinicopathologic features.
• Attenuation difference at tumor-parenchyma interface (delta 3) emerged as the most decisive imaging feature, enabling further stratification of patients into distinct prognostic subtypes by tumor size.
• High delta 3 signifies sharper contrast between tumor and surrounding pancreas, correlating with more aggressive histologic grades and less extensive tumor fibrous stromal fractions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 6:394–424CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 6:394–424CrossRef
2.
go back to reference Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 1:7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 1:7–30CrossRef
4.
go back to reference Agarwal B, Correa AM, Ho L (2008) Survival in pancreatic carcinoma based on tumor size. Pancreas 1:e15–e20CrossRef Agarwal B, Correa AM, Ho L (2008) Survival in pancreatic carcinoma based on tumor size. Pancreas 1:e15–e20CrossRef
5.
go back to reference Kang MJ, Jang JY, Kim SW (2016) Surgical resection of pancreatic head cancer: what is the optimal extent of surgery? Cancer Lett 2:259–265CrossRef Kang MJ, Jang JY, Kim SW (2016) Surgical resection of pancreatic head cancer: what is the optimal extent of surgery? Cancer Lett 2:259–265CrossRef
6.
go back to reference Franko J, Hugec V, Lopes TL, Goldman CD (2013) Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm. Ann Surg Oncol 2:357–361CrossRef Franko J, Hugec V, Lopes TL, Goldman CD (2013) Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm. Ann Surg Oncol 2:357–361CrossRef
7.
go back to reference Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 1:165–174CrossRef Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 1:165–174CrossRef
8.
go back to reference de Jong MC, Li F, Cameron JL et al (2011) Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol 7:656–662CrossRef de Jong MC, Li F, Cameron JL et al (2011) Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol 7:656–662CrossRef
9.
go back to reference El Nakeeb A, El Shobary M, El Dosoky M et al (2014) Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience). Hepatogastroenterology 133:1426–1438 El Nakeeb A, El Shobary M, El Dosoky M et al (2014) Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience). Hepatogastroenterology 133:1426–1438
10.
go back to reference Marchegiani G, Andrianello S, Malleo G et al (2017) Does size matter in pancreatic cancer?: reappraisal of tumour dimension as a predictor of outcome beyond the TNM. Ann Surg 1:142–148CrossRef Marchegiani G, Andrianello S, Malleo G et al (2017) Does size matter in pancreatic cancer?: reappraisal of tumour dimension as a predictor of outcome beyond the TNM. Ann Surg 1:142–148CrossRef
11.
go back to reference Tempero MA (2019) NCCN guidelines updates: pancreatic cancer. J Natl Compr Canc Netw 5(5):603–605CrossRef Tempero MA (2019) NCCN guidelines updates: pancreatic cancer. J Natl Compr Canc Netw 5(5):603–605CrossRef
12.
go back to reference Yoon SH, Lee JM, Cho JY et al (2011) Small (</= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 2:442–452CrossRef Yoon SH, Lee JM, Cho JY et al (2011) Small (</= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 2:442–452CrossRef
13.
go back to reference Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 3:764–768CrossRef Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 3:764–768CrossRef
14.
go back to reference Hata H, Mori H, Matsumoto S et al (2010) Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging 2:172–180CrossRef Hata H, Mori H, Matsumoto S et al (2010) Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging 2:172–180CrossRef
15.
go back to reference Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 8:1028–1061CrossRef Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 8:1028–1061CrossRef
16.
go back to reference Tempero MA, Malafa MP, Chiorean EG et al (2019) Pancreatic adenocarcinoma, Version 1.2019. J Natl Compr Canc Netw 3:202–210CrossRef Tempero MA, Malafa MP, Chiorean EG et al (2019) Pancreatic adenocarcinoma, Version 1.2019. J Natl Compr Canc Netw 3:202–210CrossRef
17.
go back to reference Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology 1:291–304.e1CrossRef Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology 1:291–304.e1CrossRef
18.
go back to reference Tamada T, Ito K, Kanomata N et al (2016) Pancreatic adenocarcinomas without secondary signs on multiphasic multidetector CT: association with clinical and histopathologic features. Eur Radiol 3:646–655CrossRef Tamada T, Ito K, Kanomata N et al (2016) Pancreatic adenocarcinomas without secondary signs on multiphasic multidetector CT: association with clinical and histopathologic features. Eur Radiol 3:646–655CrossRef
19.
go back to reference Padilla-Thornton AE, Willmann JK, Jeffrey RB (2012) Adenocarcinoma of the uncinate process of the pancreas: MDCT patterns of local invasion and clinical features at presentation. Eur Radiol 5:1067–1074CrossRef Padilla-Thornton AE, Willmann JK, Jeffrey RB (2012) Adenocarcinoma of the uncinate process of the pancreas: MDCT patterns of local invasion and clinical features at presentation. Eur Radiol 5:1067–1074CrossRef
20.
go back to reference Loizou L, Albiin N, Leidner B et al (2016) Multidetector CT of pancreatic ductal adenocarcinoma: effect of tube voltage and iodine load on tumour conspicuity and image quality. Eur Radiol 11:4021–4029CrossRef Loizou L, Albiin N, Leidner B et al (2016) Multidetector CT of pancreatic ductal adenocarcinoma: effect of tube voltage and iodine load on tumour conspicuity and image quality. Eur Radiol 11:4021–4029CrossRef
21.
go back to reference Kim JH, Park SH, Yu ES et al (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 1:87–96CrossRef Kim JH, Park SH, Yu ES et al (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 1:87–96CrossRef
22.
go back to reference Fukukura Y, Takumi K, Higashi M et al (2014) Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma. Eur J Radiol 4:612–619CrossRef Fukukura Y, Takumi K, Higashi M et al (2014) Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma. Eur J Radiol 4:612–619CrossRef
23.
go back to reference Vyas SJ, Puri YS, John BJ et al (2016) Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: a retrospective cohort study. J Cancer Res Ther 1:417–421CrossRef Vyas SJ, Puri YS, John BJ et al (2016) Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: a retrospective cohort study. J Cancer Res Ther 1:417–421CrossRef
24.
go back to reference Koay EJ, Lee Y, Cristini V et al (2018) A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clin Cancer Res 23:5883–5894CrossRef Koay EJ, Lee Y, Cristini V et al (2018) A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clin Cancer Res 23:5883–5894CrossRef
25.
go back to reference Gu J, Saiyin H, Fu D, Li J (2018) Stroma - a double-edged sword in pancreatic cancer: a lesson from targeting stroma in pancreatic cancer with hedgehog signaling inhibitors. Pancreas 4:382–389CrossRef Gu J, Saiyin H, Fu D, Li J (2018) Stroma - a double-edged sword in pancreatic cancer: a lesson from targeting stroma in pancreatic cancer with hedgehog signaling inhibitors. Pancreas 4:382–389CrossRef
26.
go back to reference Bijlsma MF, van Laarhoven HW (2015) The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal. Cancer Metastasis Rev 1:97–114CrossRef Bijlsma MF, van Laarhoven HW (2015) The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal. Cancer Metastasis Rev 1:97–114CrossRef
27.
go back to reference Hattori Y, Gabata T, Matsui O et al (2009) Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol 25:3114–3121CrossRef Hattori Y, Gabata T, Matsui O et al (2009) Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol 25:3114–3121CrossRef
28.
go back to reference Zhu L, Shi X, Xue H et al (2016) CT imaging biomarkers predict clinical outcomes after pancreatic cancer surgery. Medicine (Baltimore) 5:e2664 Zhu L, Shi X, Xue H et al (2016) CT imaging biomarkers predict clinical outcomes after pancreatic cancer surgery. Medicine (Baltimore) 5:e2664
29.
go back to reference Lee S, Kim SH, Park HK, Jang KT, Hwang JA, Kim S (2018) Pancreatic ductal adenocarcinoma: rim enhancement at MR imaging predicts prognosis after curative resection. Radiology 2:456–466CrossRef Lee S, Kim SH, Park HK, Jang KT, Hwang JA, Kim S (2018) Pancreatic ductal adenocarcinoma: rim enhancement at MR imaging predicts prognosis after curative resection. Radiology 2:456–466CrossRef
30.
go back to reference Saka B, Balci S, Basturk O et al (2016) Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: </=2, pT2: >2-</=4, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol 6:2010–2018 Saka B, Balci S, Basturk O et al (2016) Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: </=2, pT2: >2-</=4, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol 6:2010–2018
31.
go back to reference Allen PJ, Kuk D, Castillo CF et al (2017) Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg 1:185–191CrossRef Allen PJ, Kuk D, Castillo CF et al (2017) Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg 1:185–191CrossRef
32.
go back to reference Tummers WS, Groen JV, Sibinga Mulder BG et al (2019) Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 8:1055–1065CrossRef Tummers WS, Groen JV, Sibinga Mulder BG et al (2019) Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 8:1055–1065CrossRef
33.
go back to reference Petrucciani N, Nigri G, Debs T et al (2016) Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology 6:1037–1043CrossRef Petrucciani N, Nigri G, Debs T et al (2016) Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology 6:1037–1043CrossRef
35.
go back to reference Bae JS, Kim JH, Joo I, Chang W, Han JK (2019) MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer. Eur Radiol 7:3714–3724CrossRef Bae JS, Kim JH, Joo I, Chang W, Han JK (2019) MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer. Eur Radiol 7:3714–3724CrossRef
Metadata
Title
Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection
Authors
Xiaoli Cai
Feng Gao
Yafei Qi
Gongyu Lan
Xianyi Zhang
Ruoyun Ji
Youli Xu
Chang Liu
Yu Shi
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 9/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06853-2

Other articles of this Issue 9/2020

European Radiology 9/2020 Go to the issue